This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jun;11(6):301.

doi: 10.1038/nrclinonc.2014.85. Epub 2014 May 20.

Melanoma: you can have your cake and eat it!

Lisa Hutchinson

PMID: 24840077
DOI: 10.1038/nrclinonc.2014.85

Comment

Melanoma: you can have your cake and eat it!

Lisa Hutchinson. Nat Rev Clin Oncol. 2014 Jun.

. 2014 Jun;11(6):301.

doi: 10.1038/nrclinonc.2014.85. Epub 2014 May 20.

Author

Lisa Hutchinson

PMID: 24840077
DOI: 10.1038/nrclinonc.2014.85

No abstract available

PubMed Disclaimer

Comment on

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine.
Grob JJ, Amonkar MM, Martin-Algarra S, Demidov LV, Goodman V, Grotzinger K, Haney P, Kämpgen E, Karaszewska B, Mauch C, Miller WH Jr, Millward M, Mirakhur B, Rutkowski P, Chiarion-Sileni V, Swann S, Hauschild A. Grob JJ, et al. Ann Oncol. 2014 Jul;25(7):1428-1436. doi: 10.1093/annonc/mdu154. Epub 2014 Apr 25. Ann Oncol. 2014. PMID: 24769640 Clinical Trial.

References

1. Ann Oncol. 2014 Jul;25(7):1428-1436 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information